US 11737993
Multiple myeloma treatment
granted A61KA61K31/165A61K9/0019
Quick answer
US patent 11737993 (Multiple myeloma treatment) held by VANDA PHARMACEUTICALS INC. expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/165, A61K9/0019, A61K9/0053, A61P